Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Non-cash Items (2016 - 2019)

Historic Non-cash Items for Akebia Therapeutics (AKBA) over the last 4 years, with Q4 2019 value amounting to $13.5 million.

  • Akebia Therapeutics' Non-cash Items rose 47414.66% to $13.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was $13.5 million, marking a year-over-year increase of 47414.66%. This contributed to the annual value of $13.5 million for FY2019, which is 11016.4% up from last year.
  • According to the latest figures from Q4 2019, Akebia Therapeutics' Non-cash Items is $13.5 million, which was up 47414.66% from $2.4 million recorded in Q4 2018.
  • In the past 5 years, Akebia Therapeutics' Non-cash Items ranged from a high of $21.9 million in Q4 2017 and a low of $2.4 million during Q4 2018
  • Over the past 4 years, Akebia Therapeutics' median Non-cash Items value was $12.0 million (recorded in 2016), while the average stood at $12.1 million.
  • Per our database at Business Quant, Akebia Therapeutics' Non-cash Items crashed by 8927.95% in 2018 and then soared by 47414.66% in 2019.
  • Over the past 4 years, Akebia Therapeutics' Non-cash Items (Quarter) stood at $10.4 million in 2016, then soared by 110.13% to $21.9 million in 2017, then plummeted by 89.28% to $2.4 million in 2018, then skyrocketed by 474.15% to $13.5 million in 2019.
  • Its Non-cash Items was $13.5 million in Q4 2019, compared to $2.4 million in Q4 2018 and $21.9 million in Q4 2017.